
Science Resources RSS Feeds
|
 |
 |
 |
Improved estrogen reception may sharpen fuzzy memory
July 30, 2008
GAINESVILLE, Fla. - Estrogen treatments may sharpen mental performance in women with certain medical conditions, but University of Florida researchers suggest that recharging a naturally occurring estrogen receptor in the brain may also clear cognitive cobwebs. The discovery suggests that drugs can be developed to offset "senior moments" related to low estrogen levels, as well as to protect against neurological diseases, all while avoiding the problems associated with adding estrogen to the body.
Writing online in Molecular Therapy in July, scientists with UF's McKnight Brain Institute describe how they improved thought processes in female mice bred with the inability to produce estrogen receptor-alpha, a protein apparently necessary for healthy learning and memory.
"We were able to restore function in these animals, not by dosing them with estrogen, but by enabling them to use the estrogen that was naturally present in their bodies," said Tom Foster, Ph.D., the Evelyn F. McKnight chair for brain research in memory loss at the UF College of Medicine. "We discovered that you can affect the estrogen receptor directly in the hippocampus, right where it's needed to address memory and spatial learning."
Changes in the estrogen receptor have been associated with age-related memory deficits and an increased incidence of Alzheimer's disease among women. In addition, previous studies have shown estrogen replacement may improve cognition in postmenopausal women and younger women with low estrogen levels. Estrogen also appears to protect against Alzheimer's disease and dementia.
The downside is that estrogen is a powerful hormone that has far-reaching effects throughout the body. It has been associated with a slight increase in women's risk for breast cancer, heart disease in patients with existing cardiovascular problems, and stroke.
"Estrogen may act as a growth agent for cancer, but in the brain, it appears to maintain health and counteract stress," Foster said. "We wanted to come back and enhance the signaling pathway that makes estrogen functional. We used a gene therapy technique that enables us to target the brain, but ultimately there could be a pharmaceutical that enhances the signaling pathway solely in the brain."
The mice had unusually low levels of estrogen because their ovaries were removed at an early age. However, scientists were still able to rescue learning ability by delivering the correct gene to produce estrogen receptor-alpha directly to the hippocampus.
Mice that lacked the estrogen receptor showed poor ability to locate a platform hidden in a small swimming tank over a training period of several days. After receiving the gene, the mice learned to locate the platform in two days of training.
"This research shows that when the estrogen receptor-alpha is restored to adult mice that have been missing it their entire lives, it is still possible to enhance memory and learning," said John H. Morrison, Ph.D., dean of basic sciences and the Graduate School of Biological Sciences at Mount Sinai School of Medicine, who did not participate in the research. "This is good news for moving forward to develop clinical interventions and therapeutics because it appears critical damage was not done to brain circuitry during early development. There has also been debate about which of at least two estrogen receptors is key to synaptic health. Clearly estrogen receptor-alpha plays a critically important role in hippocampal organization and function."
Recordings made from the brain tissue of treated mice showed signals were strongly communicated across the gaps, or synapses, between hippocampal cells, similar to what would happen with estrogen replacement.
"Investigating the impact of genetically replacing the estrogen receptor at the cellular, synaptic and behavioral levels is a scientific tour de force which provides a strong foundation for the role of estrogen receptor alpha in mediating estrogen action in the hippocampus to restore select types of memory function," said Roberta Diaz Brinton, Ph.D., a professor of pharmacology and pharmaceutical sciences and biomedical engineering at the University of Southern California, who was not involved in the study. "From a technology perspective, their technique to transfect the estrogen receptor is an exciting advance for researching steroid receptors in the brain."
Studying the effects of increasing the estrogen receptor in other brain regions may shed additional light on memory processes.
"The research brings up the idea that local activation of non-nuclear estrogen receptor-alpha is important for regulating memory processes in the hippocampus," said Teresa A. Milner, Ph.D., a professor of neuroscience at Weill Cornell Medical College, who also was also not involved in the research.
University of Florida
|
 |
Related Estrogen Receptor Current Events and Estrogen Receptor News Articles Estrogen Receptor Current Events and Estrogen Receptor News RSS Hormone mix could cut breast cancer risk and treat symptoms of menopause The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk.
Novel, soy-based SE5-OH containing Natural S-equol supplement reduced hot flash frequency by nearly 59 percent SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women.
Molecular imaging holds promise for early intervention in common uterine cancer A promising new molecular imaging technique may provide physicians and patients with a noninvasive way to learn more information about a type of cancer of the uterus lining called "endometrial carcinoma"-one of the most common malignant female tumors.
Medications Effective in Reducing Risks for Breast Cancer Can Also Cause Serious Side Effects Three drugs that reduce a woman's chance of getting breast cancer also have been shown to cause adverse effects, according to a new report from the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health & Human Services.
Long-term tamoxifen use increases risk of an aggressive, hard to treat type of second breast cancer While long-term tamoxifen use among breast cancer survivors decreases their risk of developing the most common, less aggressive type of second breast cancer, such use is associated with a more than four-fold increased risk of a more aggressive, difficult-to-treat type of cancer in the breast opposite, or contralateral, to the initial tumor.
Low-dose estrogen shown safe and effective for metastatic breast cancer When estrogen-lowering drugs no longer control metastatic breast cancer, the opposite strategy might work. Raising estrogen levels benefited 30 percent of women whose metastatic breast cancer no longer responded to standard anti-estrogen treatment.
DACH1 a key protein for tumor suppression in ER+ breast cancer Researchers from the Kimmel Cancer Center at Jefferson have identified a protein relationship that may be an ideal treatment target for ER+ breast cancer.
Study identifies how tamoxifen stimulates uterine cell growth and cancer UCSF researchers have identified a new "feed-forward" pathway linking estrogen receptors in the membrane of the uterus to a process that increases local estrogen levels and promotes cell growth.
Newly appreciated membrane estrogen receptor important therapeutic target for breast cancer New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer.
A new take on growth factor signaling in tamoxifen resistance Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study, published in the open access journal BMC Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling. More Estrogen Receptor Current Events and Estrogen Receptor News Articles
|
 |
|
|
Belamcanda chinensis and the thereof purified tectorigenin have selective estrogen receptor modulator activities.(research findings): An article from: ... Journal of Phytotherapy & Phytopharmacology
by D. Seidlova-Wuttke (Author), O. Hesse (Author), H. Jarry (Author), G. Rimoldi (Author), P. Thelen (Author), V. Christoffel (Author), W. Wuttke (Author)
This digital document is an article from Phytomedicine: International Journal of Phytotherapy & Phytopharmacology, published by Urban & Fischer Verlag on July 1, 2004. The length of the article is 7066 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Belamcanda chinensis and the thereof purified tectorigenin have selective estrogen receptor modulator activities.(research findings) Author: D. Seidlova-Wuttke Publication: Phytomedicine: International Journal of Phytotherapy & Phytopharmacology (Refereed) Date: July 1, 2004 Publisher: Urban & Fischer Verlag Volume:...
|
![Development of a novel method for screening of estrogenic compounds using nano-sized bacterial magnetic particles displaying estrogen receptor [An article from: Analytica Chimica Acta]](http://ecx.images-amazon.com/images/I/415FBN4EPVL._SL160_.jpg)
|
Development of a novel method for screening of estrogenic compounds using nano-sized bacterial magnetic particles displaying estrogen receptor [An article from: Analytica Chimica Acta]
by T. Yoshino (Author), F. Kato (Author), H. Takeyama (Author), M. Nakai (Author), Yakabe (Author)
This digital document is a journal article from Analytica Chimica Acta, published by Elsevier in 2005. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.
Description: In this study, nano-sized bacterial magnetic particles (BMPs) displaying human estrogen receptor ligand binding domain (ERLBD) on the surface was successfully produced by the magnetic bacterium, Magnetospirillum magneticum AMB-1. Furthermore, a non-isotopic binding assay for estrogenic compounds using the BMPs displaying ERLBD was developed. A BMP membrane-specific protein, Mms16, was used as an anchor molecule to localize ERLBD on the surface of BMPs. ERLBD-BMP complexes were simply extracted by magnetic...
|
![Estrogen modulates place learning through estrogen receptors in the hippocampus [An article from: Neurobiology of Learning and Memory]](http://ecx.images-amazon.com/images/I/51T0MTGZBVL._SL160_.jpg)
|
Estrogen modulates place learning through estrogen receptors in the hippocampus [An article from: Neurobiology of Learning and Memory]
by L. Zurkovsky (Author), S.L. Brown (Author), D.L. Korol (Author)
This digital document is a journal article from Neurobiology of Learning and Memory, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.
Description: Moderate elevations in circulating estradiol enhance learning in tasks that tap place learning strategies such as those requiring the use of extramaze cues. Use of place learning strategies is particularly impaired by damage to the hippocampus, a structure shown to be sensitive to estrogen treatments. We have shown that direct estrogen infusions into the dorsal hippocampus, and not the dorsolateral striatum, enhance place learning, suggesting that the hippocampus may be an important modulatory site...
|
![Regulation of estrogen receptors in primary cultured hepatocytes of the amphibian Xenopus laevis as estrogenic biomarker and its application in environmental ... Biochemistry and Physiology, Part C]](http://ecx.images-amazon.com/images/I/51A51TBEEML._SL160_.jpg)
|
Regulation of estrogen receptors in primary cultured hepatocytes of the amphibian Xenopus laevis as estrogenic biomarker and its application in environmental ... Biochemistry and Physiology, Part C]
by I. Lutz (Author), S. Blodt (Author), W. Kloas (Author)
This digital document is a journal article from Comparative Biochemistry and Physiology, Part C, published by Elsevier in . The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.
Description: The present study aims to introduce the regulation of estrogen receptors (ER) in primary cultured hepatocytes of the amphibian Xenopus laevis as a further potential estrogenic biomarker. Time courses of free ER in cell cultures treated with 17@b-estradiol (E2), nonylphenol (NP), and bisphenol A (BPA) were determined by means of radioreceptorassay (RARA). All compounds led to an immediate drop of free ER followed by a significant increase. The estrogen specific induction of ER-mRNA in vitro...
|
|
|
Nuclear receptor coactivators function in estrogen receptor- and progestin receptor-dependent aspects of sexual behavior in female rats [An article from: Hormones and Behavior]
by H.A. Molenda-Figueira (Author), C.A. Williams (Author), A.L Griffin (Author)
This digital document is a journal article from Hormones and Behavior, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.
Description: The ovarian hormones, estradiol (E) and progesterone (P) facilitate the expression of sexual behavior in female rats. E and P mediate many of these behavioral effects by binding to their respective intracellular receptors in specific brain regions. Nuclear receptor coactivators, including Steroid Receptor Coactivator-1 (SRC-1) and CREB Binding Protein (CBP), dramatically enhance ligand-dependent steroid receptor transcriptional activity in vitro. Previously, our lab has shown that SRC-1 and CBP modulate estrogen...
|
|
|
Key estrogen receptor gene mutation discovered. (Clinical Rounds: May be exploitable as a prognostic factor).(Brief Article): An article from: Internal Medicine News
by Bruce Jancin (Author)
This digital document is an article from Internal Medicine News, published by International Medical News Group on April 1, 2002. The length of the article is 2913 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Key estrogen receptor gene mutation discovered. (Clinical Rounds: May be exploitable as a prognostic factor).(Brief Article) Author: Bruce Jancin Publication: Internal Medicine News (Magazine/Journal) Date: April 1, 2002 Publisher: International Medical News Group Volume: 35 Issue: 7 Page: 24(1)
Article Type: Brief Article
Distributed by...
|
|
|
Tamoxifen Not for Receptor-Negative Breast Ca.(estrogen-receptor negative breast cancer): An article from: Internal Medicine News
by Robert Finn (Author)
This digital document is an article from Internal Medicine News, published by International Medical News Group on July 1, 2001. The length of the article is 958 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Tamoxifen Not for Receptor-Negative Breast Ca.(estrogen-receptor negative breast cancer) Author: Robert Finn Publication: Internal Medicine News (Magazine/Journal) Date: July 1, 2001 Publisher: International Medical News Group Volume: 34 Issue: 13 Page: 12
Distributed by Thomson...
|
|
|
Social dominance regulates androgen and estrogen receptor gene expression [An article from: Hormones and Behavior]
by S.S. Burmeister (Author), V. Kailasanath (Author), R.D. Fernald (Author)
This digital document is a journal article from Hormones and Behavior, published by Elsevier in 2007. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.
Description: In Astatotilapia burtoni, dominant males have higher levels of sex steroid hormones than subordinate males. Because of the complex regulatory interactions between steroid hormones and receptors, we asked whether dominance is also associated with variation in sex steroid receptor gene expression. Using quantitative PCR, we compared the expression of specific subtypes of androgen (AR) and estrogen (ER) receptor genes between dominant and subordinated males in 3 divisions of the brain, the pituitary, and the...
|
|
|
Statins may curb ER-negative breast cancer risk: benefit associated with lipophilic statins.(Women's Health)(estrogen receptor): An article from: Internal Medicine News
by Bruce Jancin (Author)
This digital document is an article from Internal Medicine News, published by Thomson Gale on January 1, 2006. The length of the article is 621 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Statins may curb ER-negative breast cancer risk: benefit associated with lipophilic statins.(Women's Health)(estrogen receptor) Author: Bruce Jancin Publication: Internal Medicine News (Magazine/Journal) Date: January 1, 2006 Publisher: Thomson Gale Volume: 39 Issue: 1 Page: 1(2)
Distributed by Thomson...
|
![Upregulation of estrogen receptor @a and vitellogenin in eelpout (Zoarces viviparus) by waterborne exposure to 4-tert-octylphenol and 17@b-estradiol [An ... Biochemistry and Physiology, Part C]](http://ecx.images-amazon.com/images/I/51A51TBEEML._SL160_.jpg)
|
Upregulation of estrogen receptor @a and vitellogenin in eelpout (Zoarces viviparus) by waterborne exposure to 4-tert-octylphenol and 17@b-estradiol [An ... Biochemistry and Physiology, Part C]
by T.K. Andreassen (Author), K. Skjoedt (Author), B. Korsgaard (Author)
This digital document is a journal article from Comparative Biochemistry and Physiology, Part C, published by Elsevier in 2005. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.
Description: The mechanisms of action of an estrogenic chemical have been examined in a viviparous fish the eelpout (Zoarces viviparus), by identification of an upregulated estrogenic pathway-the induction of hepatic estrogen receptor mRNA, hepatic estrogen binding activity and plasma vitellogenin. A relative quantitative RT-PCR assay has been established to measure hepatic estrogen receptor @a (ER) mRNA levels in eelpout. Assay conditions were optimised using control and induced samples to...
|
|